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Abstract
“Chylous ascites is a rare presentation of peritoneal effusion. The signet ring cell gastric adenocarcinoma is also 
relatively rare presentation of gastric cancer. We present a quite rare case of chylous ascites associated with signet 
ring cell gastric adenocarcinoma. Case report: a 47-years-old Caucasian man presented to our emergency department 
with abdominal distention. The abdominal ultra-sound showed high volume ascites and the diagnostic paracentesis 
revealed milk-like peritoneal fluid rich in triglycerides.  He was underwent to medium chain triglycerides based diet, total 
parenteric diet and treatment with somatostatin without response. Due to presented digestive hemorrhagic events, upper 
digestive endoscopy was performed and revealed signet ring cells gastric adenocarcinoma on biopsy. The patient died 
in disseminated intravascular coagulation context. Conclusion: chylous asicites is a rare presentation of ascites and it 
may be associated with abdominal neoplasm. The prompt diagnosis is important for optimize the etiology evaluation 
and therapeutically approach.”
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Introduction
Chylous ascites is defined as accumulation of milk-like 
peritoneal fluid rich in triglycerides in the abdominal cavity 
due to the presence of thoracic or intestinal lymph. [1] It 
is related to disruption of the lymphatic system caused 
by traumatic injury, congenital defects of the lymphatic 
system, inflammatory disease, liver cirrhosis or by benign 
or malignant process.[2,3] It is a very rare entity and its 
incidence is about 1 per 20.464 hospital admissions.[3] 
Malignant ascites usually account 10% of all cases of ascites 
and it may be caused by ovarian, endometrial, breast, 
esophageal, lung, colorectal, prostate or gastric cancer.[4,5] 
Signet ring cell gastric adenocarcinoma is a relatively rare 
disease and its incidence is between 3.4%.[6] and 15.3%[7] 
of all gastric cancers. Patients with this histology tend to 
be young and female.[6] This paper reports a quite rare case 
of chylous ascites associated with signet ring cell gastric 
adenocarcinoma and highlights the difficulties regarding 
diagnoses and some literature issues.
Case Report
A 47-year-old Caucasian man presented to our emergency 
department with abdominal distention, loss of weight 
about 10% last month, postprandial fullness, asthenia, 
and anorexia. He had medical history of high alcohol 
consumption about 100 g daily, myocardial infarction in 
1997, and percutaneous coronary angioplasty with stent 
placement. He had no surgical and familial relevant history. 
On physical examination, he had ascites without signs 
Chylous ascites due to signet ring cell gastric 
adenocarcinoma
RA de Mello1,2,3, T Gregório2,4, T Cardoso2,3
1Department of Medical Oncology, Portuguese Oncology Institute, Rua Dr. Bernardino de Almeida, 
2Internal Medicine Department of Hospital São João, 3Medicine and 4Biochemistry Departments, 
Faculty of Medicine, University of Porto, Alameda Prof. Hernani Monteiro, Porto, Portugal
Case Report





488 Nigerian Journal of Clinical Practice • Oct-Dec 2012 • Vol 15 • Issue 4
de Mello, et al.: Chylous ascites and gastric cancer
of chronic hepatic disease. The abdominal ultrasound 
confirmed ascites and also showed mild hepatomegaly.
Hematology and biochemistry investigation on presentation 
demonstrated thrombocytopenia (65000/µL), alteration in 
coagulation study (Activated Partial Tromboplastin Time 
42 seconds and fibrinogen level 534 mg/dL), high C-reactive 
protein (105.3 mg/dL), elevated alkaline phosphatase 
(808 UI/L) and gama glutamyl transferase (71 UI/L), and 
normal transaminases and bilirrubins levels.
He was transferred to the internal medicine ward. 
Paracentesis was performed and showed milk-like fluid rich 
in triglycerides (2225 mg/dL), diagnosing chylous ascitis. 
He started medium chain triglycerides (MCT)- based 
diet. The patient did not have good response and thus 
it was performed total parenteral nutrition (TPN) and 
somatostatin therapy. In order to exclude obstructive lesions, 
thoracic-abdominal computed tomography (CT) scan 
was performed and it revealed para-tracheal, mediastinic, 
tracheobronchic and prevascular lymph node enlargement 
[Figure 1]. The patient followed with hemorrhagic events 
including hematuria and melena. Upper digestive endoscopy 
showed infiltrative ulcerated gastric lesions with signs 
of bleeding [Figure 2]. The lesions histology revealed 
signet ring cell gastric adenocarcinoma. He evolved with 
progressive thrombocytopenia refractory to transfusion 
support, bleeding difficult to control, worsening of anemia 
with emergence of abundant schizocytes in blood smear and 
a disproportionate increase of indirect bilirrubin; thus, it 
was diagnosed disseminated intravascular coagulation. The 
patient developed respiratory failure and died on day 20 of 
hospitalization.
Discussion
In 1627, Asellius described the lymphatic system in 
a Later, the first chylous ascites case was observed by 
Morton in 1691 in an 18-month-old boy with disseminated 
tuberculosis.[2,3] The lymphatic system is an important rout 
Figure 1: Thoracic-abdominal CT showing para-tracheal, tracheal-bronchial and pre-vascular lymph node enlargement
dc
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Figure 2: Upper digestive endoscopy showing signs of gastric bleeding (a) and malignant lesion in the antrum (b)
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where fluids and proteins can flow from the intestinal 
spaces to the vascular system. It also plays an essential 
role in absorption of lipid and lipid soluble vitamins.[2,8] 
Interstitial resistance really affects the apparent lymphatic 
uptake rate. Normally, lymph and interstitial fluid have 
the same concentration and also osmotic pressure.[8] 
Molecules enter into the lymphatic capillaries by the 
influence of hydrostatic and oncotic forces and the 
vesicular transport runs in fluid throughout the following 
rout: initial lynphatics, prenodal collecting lymphatic, 
lymph nodes, postnodal collecting lymphatic, lymphatic 
trunks, and cisterna chyli and thoracic ducts. [8] Thus, 
mechanisms of the underlying disease may be related 
to primary lymph node fibrosis caused by the tumor 
obstructing the flow from the gut to the cysterna chili 
resulting lymphatic fluid into the abdominal cavity, 
exudation of lymph through the walls of retroperitoneal 
megalymphatics and/or dilated retroperitoneal lymphatic 
vessels caused by acquired thoracic duct obstruction.[2]
In this report, despite the patient had high alcohol 
consumption, he was without signs of chronic hepatic 
disease. He also did not have medical history of traumatic 
injury and no infection disease, such as tuberculosis. In 
the clinical field, constitutional symptoms are common 
but not specific, such as anorexia and weakness.[1,3] 
Furthermore, abdominal pain, weight loss, diarrhea, 
steatorrhea, malnutrition, edema, enlarged lymph nodes, 
early satiety, fevers, and night sweats are others related 
features.[1] Our patient initially complained of weight loss, 
anorexia (suggesting also neoplasm associated disease), 
and weakness. Others general aspects found were the 
enlargement lymph nodes at CT scan, but without signs 
of obstruction. Despite CT of the abdomen being an 
important imaging exam to diagnose ascites,[1] in this case 
the ultrasound of the abdomen was decisive to confirm 
this hypothesis and lead to abdominal paracentesis. This 
procedure is the most important tool in evaluation and 
management of patients with ascites[2] and herein allowed 
the possibility of characterizing the ascites fluid as milk-like 
pattern and performs subsequent analysis that disclosed 
high triglycerides levels. The recommendations approach 
implies conservative treatment such as MCT-based diet, 
TPN and subsequent somatostatin or its analogs.[3,9] The 
surgical approach is only recommended when conservative 
treatment fails.[3] Signet ring cell gastric adenocarcinoma 
occurs in a reduced number of gastric cancers. In early 
stages, 5-year overall survival is about 90%; and in 
advanced stages, 42.5%.[6] The history of this disease is 
quite aggressive and it is often diagnosed in advanced 
stages. The treatment for advanced stage is usually with 
chemotherapy based on cisplatin/fluorouacil. [10] Our 
patient had a very aggressive progression, with gastric 
bleeding due to gastric cancer and it was not possible 
subsequent surgical proposal to address chylous ascites. 
Unfortunately, he was not early diagnosed and died after 
disseminated intravascular coagulation (DIC) complication 
and respiratory failure during hospitalization.
Disseminated intravascular coagulation is a clinical-
pathological syndrome characterized by evidence of 
consumption and proteolytic degradation only or in 
combination with hemorrhagic and thrombotic events.[11] 
DIC may occurs in patients with advanced gastric cancer 
due to disseminated fibrin and microthrombi and it has 
a dark prognosis.[12] Those patients usually die within 
1-4 weeks if not adequately treated.[11] Conventional 
treatment modalities, such as fresh frozen plasma platelet 
transfusion, sometimes are disappointed. However, 
palliative chemotherapy regimen based on etoposide 
40 mg/m2, epirubicin 10 mg/m2, cisplatin 25 mg/m2, 
5-fluorouracil 2200 mg/m2, and leucovorin 120 mg/m2 in 
those eligibile patients previously showed stabilization of 
clinical and laboratorial evidence of DIC after starting 
chemotherapy.[13] Also, others regimens can improve 
the outcome of DIC in the context of advanced gastric 
cancer, such as methotrexate 100 mg/m2 plus 5-fluorouracil 
600 mg/ m2.[14] Thus, although gastric cancer that 
initially presents with DIC has poor prognosis, palliative 
chemotherapy seems to prolong overall survival when 
compared to best supportive care in some studies conducted 
in the Korean population.[15]
Conclusion
Chylous ascites is a rare presentation of ascites and sometimes 
it may be associated with neoplasm disorders.[4] Signet ring 
cell gastric adenocarcinoma is also rarely associated with 
this entity.[6] The prompt diagnosis is important to optimize 
approach and outcome of the underlying cancer. Despite no 
guidelines for malignant chylous ascites are well defined,[3] 
conservative treatment may improve the life's quality of 
this type of patients. Also, when advanced gastric cancer is 
presented with DIC, palliative chemotherapy can improve 
outcome.
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A free application to browse and search the journal’s content is now available for Android based 
mobiles and devices. The application provides “Table of Contents” of the latest issues, which 
are stored on the device for future offline browsing. Internet connection is required to access the 
back issues and search facility. The application is compatible with all the versions of Android. The 
application can be downloaded from https://market.android.com/details?id=comm.app.medknow. 
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